Access to European Union law
<a href="https://eur-lex.europa.eu/content/help/eurlex-content/experimental-features.html" target="_blank">More about the experimental features corner</a>
Choose the experimental features you want to try
EUR-Lex
Access to European Union law

This document is an excerpt from the EUR-Lex website

You are here
Use quotation marks to search for an "exact phrase". Append an asterisk (*) to a search term to find variations of it (transp*, 32019R*). Use a question mark (?) instead of a single character in your search term to find variations of it (ca?e finds case, cane, care).
Search tips
Need more search options? Use the Advanced search

Document 32022D1377

    Commission Implementing Decision (EU) 2022/1377 of 4 August 2022 amending the Annex to Decision 2007/453/EC as regards the BSE status of France (notified under document C(2022) 5507) (Text with EEA relevance)

    C/2022/5507

    OJ L 206, 8.8.2022, p. 51–54 (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

    Legal status of the document In force

    ELI: http://data.europa.eu/eli/dec_impl/2022/1377/oj

    Date of document:
    04/08/2022; Date of adoption
    Date of effect:
    08/08/2022; Takes effect Date notif.
    Date of notification:
    08/08/2022; The act was notified but the date of notification is not available on EUR-Lex – the date of publication is used instead.
    Date of end of validity:
    No end date
    Author:
    European Commission, Directorate-General for Health and Food Safety
    Responsible body:
    Directorate-General for Health and Food Safety, SANTE
    Form:
    Implementing decision
    Addressee:
    The Member States
    Additional information:
    EEA relevance
    Treaty:
    Treaty on the Functioning of the European Union
    Legal basis:
    Link
    Link
    Link
    Select all documents mentioning this document
    Modifies:
    Relation Act Comment Subdivision concerned From To
    Modifies 32007D0453 Replacement annex 08/08/2022
    Link

    8.8.2022   

    EN

    Official Journal of the European Union

    L 206/51

    COMMISSION IMPLEMENTING DECISION (EU) 2022/1377

    of 4 August 2022

    amending the Annex to Decision 2007/453/EC as regards the BSE status of France

    (notified under document C(2022) 5507)

    (Text with EEA relevance)

    THE EUROPEAN COMMISSION,

    Having regard to the Treaty on the Functioning of the European Union,

    Having regard to Regulation (EC) No 999/2001 of the European Parliament and of the Council of 22 May 2001 laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies (1), and in particular Article 5(2), third subparagraph, thereof,

    Whereas:

    (1)

    Regulation (EC) No 999/2001 provides that Member States or third countries or regions thereof (countries or regions) are to be classified according to their bovine spongiform encephalopathy (BSE) status into one of three categories: negligible BSE risk, controlled BSE risk and undetermined BSE risk.

    (2)

    Article 5(2) of Regulation (EC) No 999/2001 provides that if the World Organisation for Animal Health (OIE) has placed an applicant country in one of the three BSE categories, a re-assessment of the BSE categorisation at Union level may be decided.

    (3)

    Commission Decision 2007/453/EC (2) lists the BSE status of countries or regions according to their BSE risk in Parts A, B or C of the Annex to that act. The countries or regions listed in Part A of that Annex are regarded as having a negligible BSE risk, those listed in Part B are regarded as having a controlled BSE risk, while Part C of that Annex provides that countries or regions not listed in Part A or B are to be regarded as having an undetermined BSE risk.

    (4)

    France currently falls within Part B of the Annex to Decision 2007/453/EC under countries or regions with a controlled BSE risk.

    (5)

    On 24 May 2022, the OIE World Assembly of Delegates adopted Resolution No 15, ‘Recognition of the Bovine Spongiform Encephalopathy Risk Status of Members’ (3), in view of an entry into force on 27 May 2022. That Resolution recognised France as having a negligible BSE risk, in accordance with the Terrestrial Animal Health Code of the OIE. After reassessment of the situation at Union level, stemming from OIE Resolution No 15, the Commission has considered that the new OIE BSE status of France should be reflected in the Annex to Decision 2007/453/EC.

    (6)

    The list of countries or regions in the Annex to Decision 2007/453/EC should therefore be amended so that France is listed in Part A of that Annex under countries or regions with a negligible BSE risk.

    (7)

    The Annex to Decision 2007/453/EC should therefore be amended accordingly.

    (8)

    The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on Plants, Animals, Food and Feed,

    HAS ADOPTED THIS DECISION:

    Article 1

    The Annex to Decision 2007/453/EC is replaced by the text set out in the Annex to this Decision.

    Article 2

    This Decision is addressed to the Member States.

    Done at Brussels, 4 August 2022.

    For the Commission

    Stella KYRIAKIDES

    Member of the Commission

    (1)   OJ L 147, 31.5.2001, p. 1.

    (2)  Commission Decision 2007/453/EC of 29 June 2007 establishing the BSE status of Member States or third countries or regions thereof according to their BSE risk (OJ L 172, 30.6.2007, p. 84).

    (3)  https://www.woah.org/app/uploads/2022/05/a-r15-2022-bse-final-1.pdf

    ANNEX

    The Annex to Decision 2007/453/EC is replaced by the following:

    ‘ANNEX

    LIST OF COUNTRIES OR REGIONS

    A.   Countries or regions with a negligible BSE risk

    Member States

    —

    Belgium

    —

    Bulgaria

    —

    Czechia

    —

    Denmark

    —

    Germany

    —

    Estonia

    —

    Ireland

    —

    Spain

    —

    France

    —

    Croatia

    —

    Italy

    —

    Cyprus

    —

    Latvia

    —

    Lithuania

    —

    Luxembourg

    —

    Hungary

    —

    Malta

    —

    Netherlands

    —

    Austria

    —

    Poland

    —

    Portugal

    —

    Romania

    —

    Slovenia

    —

    Slovakia

    —

    Finland

    —

    Sweden

    Regions of Member States  (*1)

    —

    Northern Ireland

    European Free Trade Association countries

    —

    Iceland

    —

    Liechtenstein

    —

    Norway

    —

    Switzerland

    Third countries

    —

    Argentina

    —

    Australia

    —

    Brazil

    —

    Canada

    —

    Chile

    —

    Colombia

    —

    Costa Rica

    —

    India

    —

    Israel

    —

    Japan

    —

    Jersey

    —

    Namibia

    —

    New Zealand

    —

    Panama

    —

    Paraguay

    —

    Peru

    —

    Serbia (*2)

    —

    Singapore

    —

    United States

    —

    Uruguay

    B.   Countries or regions with a controlled BSE risk

    Member States

    —

    Greece

    Third countries

    —

    Mexico

    —

    Nicaragua

    —

    South Korea

    —

    Taiwan

    —

    United Kingdom with the exception of Northern Ireland

    C.   Countries or regions with an undetermined BSE risk

    —

    Countries or regions not listed in Parts A or B.
    .

    (*1)  In accordance with the Agreement on the withdrawal of the United Kingdom of Great Britain and Northern Ireland from the European Union and the European Atomic Energy Community, and in particular Article 5(4) of the Protocol on Ireland/Northern Ireland in conjunction with Annex 2 to that Protocol, for the purposes of this Annex references to Member States include the United Kingdom in respect of Northern Ireland.

    (*2)  As referred to in Article 135 of the Stabilisation and Association Agreement between the European Communities and their Member States of the one part, and the Republic of Serbia, of the other part (OJ L 278, 18.10.2013, p. 16).’

    Top